dupilumab
regeneron,sanofi
['eosinophilic,esophagitis', 'sanofi', 'regeneron']
with , we re presenting late-breaking phase 3 investigational data in children ages 1 to 11 with eosinophilic esophagitis (eoe). learn about these results at #uegweek: 
We chase the miracles of science to improve people’s lives.
Interactions with this account must comply with the Terms: https://t.co/mXmuqtkblm